Our diagnostic solutions provide clinicians novel tools to estimate cancer aggressivity at the time of diagnosis and help them to select the most effective, and health economical therapies. CURRENT TARGET DISEASE Head and neck squamous cell carcinoma (HNSCC) Almost one million new cases annually... Read more